CIK 0001420720 · Non-accelerated filer<br>Smaller reporting company
iBio, Inc.
Sign in to watch- Ticker
- IBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262797813
- Phone
- 302 355-0650
- Business address
- 600 MADISON AVENUE, SUITE 1601, NEW YORK, NY, 10022-1737
- Former names
- iBio, Inc., iBioPharma, Inc., InB:Biotechnologies, Inc.
- 8-K Event Other events
- 8-K Event Executive or director change
- UPLOAD Other SEC-generated Letter
- 8-K Event Executive or director change · Shareholder vote results
- SC 13D/A Stake Beneficial Ownership Report
- DEFA14A Proxy Proxy Materials
- S-3 Offering Registration Statement
- 8-K/A Event Material agreement · Unregistered share sale
- 8-K Event Material agreement · Unregistered share sale
- 10-Q Report Quarterly Report
- 8-K Event Other events
- DEFA14A Proxy Proxy Materials
- SC 13D/A Stake Beneficial Ownership Report
- 4/A Insider Changes in Ownership
- DEF 14A Proxy Proxy Statement
- 8-K Event Delisting notice
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Director nominations · Other events
- DEFA14A Proxy Proxy Materials
- 8-K Event Delisting notice
Page 24 of 46 · 911 filings